MDPI and ACS Style
Harada, K.; Yamamura, T.; Muto, O.; Nakamura, M.; Sogabe, S.; Sawada, K.; Nakano, S.; Yagisawa, M.; Muranaka, T.; Dazai, M.;
et al. Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101). J. Clin. Med. 2023, 12, 1596.
https://doi.org/10.3390/jcm12041596
AMA Style
Harada K, Yamamura T, Muto O, Nakamura M, Sogabe S, Sawada K, Nakano S, Yagisawa M, Muranaka T, Dazai M,
et al. Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101). Journal of Clinical Medicine. 2023; 12(4):1596.
https://doi.org/10.3390/jcm12041596
Chicago/Turabian Style
Harada, Kazuaki, Takahiro Yamamura, Osamu Muto, Michio Nakamura, Susumu Sogabe, Kentaro Sawada, Shintaro Nakano, Masataka Yagisawa, Tetsuhito Muranaka, Masayoshi Dazai,
and et al. 2023. "Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101)" Journal of Clinical Medicine 12, no. 4: 1596.
https://doi.org/10.3390/jcm12041596
